Claire Bugos

Smoking is the most significant risk factor for developing age-related macular degeneration—the most common cause of non-reversible blindness.

Vitamin D may slow aging, melatonin hangover is real, and the TikTok ironmaxxing trend helps you get iron from foods—here are five trending stories to know this week.

Federal health officials issued a warning about using Tylenol during pregnancy based on inconclusive evidence linking the drug to autism in children.

Too much screen time can cause temporary, though uncomfortable, vision symptoms, especially as we age. Some basic vision hygiene tips can minimize that discomfort.

A panel of CDC advisors voted against a proposal to require prescriptions for COVID vaccines, but said people must now discuss the risks and benefits of the shot with a doctor before getting it.

Most people have a sore arm immediately after being vaccinated against COVID-19, and more systemic effects like fever and chills within 8 to 12 hours.

Five trending topics of the week: omega-3s may protect against Alzheimer's, comparing whey and clear protein powders, and a case for drinking more matcha

Flu vaccines are now available nationwide. Here's what you need to know about eligibility, timing, and cost of the vaccine this year.

Five trending wellness topics of the week: grind your chia seeds, pair your oatmilk with protein and fiber, and ease gently into a weighted vest habit.

It's not easy to keep up in the ever-changing world of wellness trends. Here are some of the biggest trends of the week, and what health experts have to say about them.

Wegovy is now the second drug approved to treat advanced liver disease in people with fibrosis.

As most kidney stones contain calcium, it may reason that a calcium supplement could raise your risk of making stones. As it turns out, the mineral may be protective.

Federal regulators announced that they want to classify a kratom byproduct as a Schedule I drug.

People in highly economically developed nations tend to be less active and more overweight. A new study suggests that overeating—not physical inactivity—could explain why.

People with obesity who took Eli Lilly's daily oral GLP-1 drug orforglipron lost an average of 12.4% of their body weight, according to topline results from its first of two late-stage clinical trials.

The HHS is betting $500 million on developing a universal flu vaccine that could protect against multiple flu strains.

The ultraviolet index measures the intensity of the sun's harmful rays. Learning how to read it can help you protect your skin and eyes this summer.

Congress formalized a massive budget bill that cuts more than $1 trillion in federal health care spending to programs like Medicaid and SNAP.

Two new Omicron subvariants are gaining ground in the U.S. as some people report experiencing respiratory symptoms like "razor blade throat." Here's what we know so far.

A recent study found that older adults with diabetes who use a GLP-1 drug have double the risk of developing wet age-related macular degeneration compared to those who don't use the drugs.